GT BIOPHARMA, INC. ANNOUNCES ADDITIONAL POSITIVE DATA FROM ITS PHASE 1 CLINICAL TRIAL FOR MYASTHENIA GRAVIS AND POTENTIAL FOR ACCELERATION OF THE START OF ITS PHASE 2 TRIAL

WASHINGTON, DC / MARCH 26, 2018 / GT Biopharma Inc. (OTCQB “GTBP”…

Advancements Made With Marijuana Legalization Across The U.S.

States commonly follow the lead of others when it comes to legalization…

Canada’s Booming Marijuana Industry Foreshadows What’s To Come For The United States

Marijuana stocks have went through quite the year. Stocks have been fluctuating…